Susquehanna International Group’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.52M | Buy |
8,100
+4,100
| +103% | +$790K | ﹤0.01% | 6840 |
|
|
2025
Q4 | $757K | Buy |
4,000
+2,600
| +186% | +$481K | ﹤0.01% | 7843 |
|
|
2025
Q3 | $232K | Sell |
1,400
-400
| -22% | -$65.2K | ﹤0.01% | 10667 |
|
|
2025
Q2 | $276K | Sell |
1,800
-11,800
| -87% | -$1.76M | ﹤0.01% | 10542 |
|
|
2025
Q1 | $2.14M | Buy |
+13,600
| New | +$2.21M | ﹤0.01% | 5376 |
|
|
2024
Q4 | – | Sell |
-12,500
| Closed | -$2.22M | – | 12170 |
|
|
2024
Q3 | $2.22M | Buy |
12,500
+6,800
| +119% | +$1.21M | ﹤0.01% | 5065 |
|
|
2024
Q2 | $960K | Buy |
+5,700
| New | +$932K | ﹤0.01% | 6697 |
|
|
2023
Q3 | – | Sell |
-2,400
| Closed | -$375K | – | 12004 |
|
|
2023
Q2 | $375K | Buy |
2,400
+600
| +33% | +$95.9K | ﹤0.01% | 8986 |
|
|
2023
Q1 | $292K | Sell |
1,800
-900
| -33% | -$146K | ﹤0.01% | 9786 |
|
|
2022
Q4 | $431K | Buy |
2,700
+1,000
| +59% | +$158K | ﹤0.01% | 8251 |
|
|
2022
Q3 | $239K | Buy |
+1,700
| New | +$257K | ﹤0.01% | 10385 |
|
|
2022
Q2 | – | Sell |
-4,800
| Closed | -$778K | – | 12869 |
|
|
2022
Q1 | $778K | Buy |
4,800
+1,500
| +45% | +$243K | ﹤0.01% | 7786 |
|
|
2021
Q4 | $625K | Sell |
3,300
-2,300
| -41% | -$443K | ﹤0.01% | 8550 |
|
|
2021
Q3 | $1.13M | Sell |
5,600
-7,900
| -59% | -$1.66M | ﹤0.01% | 7241 |
|
|
2021
Q2 | $2.72M | Buy |
13,500
+5,700
| +73% | +$1.06M | ﹤0.01% | 5243 |
|
|
2021
Q1 | $1.37M | Buy |
7,800
+1,000
| +15% | +$181K | ﹤0.01% | 6909 |
|
|
2020
Q4 | $1.15M | Sell |
6,800
-700
| -9% | -$115K | ﹤0.01% | 6385 |
|
|
2020
Q3 | $1.22M | Sell |
7,500
-900
| -11% | -$146K | ﹤0.01% | 5646 |
|
|
2020
Q2 | $1.37M | Buy |
8,400
+6,400
| +320% | +$973K | ﹤0.01% | 5212 |
|
|
2020
Q1 | $256K | Sell |
2,000
-7,400
| -79% | -$997K | ﹤0.01% | 8272 |
|
|
2019
Q4 | $1.31M | Sell |
9,400
-9,700
| -51% | -$1.27M | ﹤0.01% | 5017 |
|
|
2019
Q3 | $2.25M | Buy |
19,100
+14,600
| +324% | +$1.82M | ﹤0.01% | 3960 |
|
|
2019
Q2 | $583K | Sell |
4,500
-4,500
| -50% | -$555K | ﹤0.01% | 6958 |
|
|
2019
Q1 | $1.16M | Buy |
9,000
+4,800
| +114% | +$606K | ﹤0.01% | 4758 |
|
|
2018
Q4 | $467K | Sell |
4,200
-9,700
| -70% | -$1.17M | ﹤0.01% | 6157 |
|
|
2018
Q3 | $1.9M | Buy |
13,900
+3,300
| +31% | +$429K | ﹤0.01% | 4099 |
|
|
2018
Q2 | $1.27M | Sell |
10,600
-4,500
| -30% | -$530K | ﹤0.01% | 4850 |
|
|
2018
Q1 | $1.82M | Buy |
15,100
+6,900
| +84% | +$866K | ﹤0.01% | 4097 |
|
|
2017
Q4 | $1.02M | Sell |
8,200
-23,200
| -74% | -$2.96M | ﹤0.01% | 5185 |
|
|
2017
Q3 | $4.21M | Sell |
31,400
-19,700
| -39% | -$2.57M | ﹤0.01% | 2735 |
|
|
2017
Q2 | $6.42M | Buy |
51,100
+19,300
| +61% | +$2.33M | ﹤0.01% | 2115 |
|
|
2017
Q1 | $3.79M | Buy |
31,800
+15,300
| +93% | +$1.79M | ﹤0.01% | 2680 |
|
|
2016
Q4 | $1.77M | Sell |
16,500
-37,000
| -69% | -$4.02M | ﹤0.01% | 4322 |
|
|
2016
Q3 | $6.16M | Sell |
53,500
-39,200
| -42% | -$4.47M | ﹤0.01% | 2005 |
|
|
2016
Q2 | $9.5M | Buy |
92,700
+32,000
| +53% | +$3.41M | 0.01% | 1489 |
|
|
2016
Q1 | $6.29M | Buy |
60,700
+27,900
| +85% | +$2.91M | ﹤0.01% | 2020 |
|
|
2015
Q4 | $4.16M | Buy |
32,800
+11,500
| +54% | +$1.41M | ﹤0.01% | 2780 |
|
|
2015
Q3 | $2.44M | Sell |
21,300
-6,100
| -22% | -$807K | ﹤0.01% | 3894 |
|
|
2015
Q2 | $3.69M | Buy |
27,400
+3,900
| +17% | +$518K | ﹤0.01% | 3472 |
|
|
2015
Q1 | $3.04M | Sell |
23,500
-7,000
| -23% | -$880K | ﹤0.01% | 3535 |
|
|
2014
Q4 | $3.52M | Sell |
30,500
-32,000
| -51% | -$3.61M | ﹤0.01% | 3459 |
|
|
2014
Q3 | $6.62M | Buy |
62,500
+3,900
| +7% | +$395K | ﹤0.01% | 2619 |
|
|
2014
Q2 | $5.59M | Buy |
58,600
+11,200
| +24% | +$1M | ﹤0.01% | 2893 |
|
|
2014
Q1 | $4.31M | Sell |
47,400
-24,300
| -34% | -$2.36M | ﹤0.01% | 3092 |
|
|
2013
Q4 | $6.35M | Buy |
71,700
+21,000
| +41% | +$1.76M | ﹤0.01% | 2609 |
|
|
2013
Q3 | $4.2M | Buy |
50,700
+34,800
| +219% | +$2.73M | ﹤0.01% | 2984 |
|
|
2013
Q2 | $1.09M | Buy |
+15,900
| New | +$1.11M | ﹤0.01% | 4857 |
|
Other funds holding BBH
MIM
CCA
BFG
Susquehanna International Group's BBH Position: Q1 2026 in Review
Susquehanna International Group increased its VanEck Biotech ETF (BBH) stake by 117% in Q1 2026, buying an estimated $268K and bringing the position to 2,579 shares worth $485K. The position accounts for ﹤0.01% of the portfolio, ranked #9756.
Susquehanna International Group first reported a position in BBH in Q2 2013 and has held it in 50 quarters since. The position peaked at $11M in Q4 2013. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- Susquehanna International Group held 2,579 shares of VanEck Biotech ETF worth $485K as of Q1 2026.
- Susquehanna International Group bought 1,391 VanEck Biotech ETF shares in Q1 2026, an estimated $268K.
- VanEck Biotech ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9756 holding.
- Susquehanna International Group first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 50 quarters since.
- Susquehanna International Group's VanEck Biotech ETF position peaked at $11M in Q4 2013.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.